Check-Cap's prep-free colonoscopy alternative delivers 'promising' results — 3 insights

Check-Cap's C-Scan preparation-free colonoscopy alternative delivered promising initial results in its post-CE approval trial.

Researchers tested the C-Scan system version three in 31 patients at multiple overseas centers. The system detects polyps in patients with unprepared colons.

Here's what you should know:

1. The device had 76 percent sensitivity and 80 percent specificity.

2. Independent investigators performed confirmatory colonoscopies to crosscheck the results.

3. C-Scan's newest version included better imaging density, 2D/3D testing and a motility analysis algorithm.

Final results from the trial are expected in the second quarter of 2019.

Check-Cap CEO Alex Ovadia said, "We believe that the encouraging interim results from our ongoing post CE approval study demonstrate a significant progress in the clinical performance of C-Scan compared with previously communicated CE study results for our patient-friendly, and preparation-free colon-cancer screening device."

Check-Cap will initiate a U.S.-based pilot trial in the fourth quarter of 2018.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast